Abstract
Multiple Myeloma (MM) remains an incurable disease. Scientific understanding of the biology and influence of the microenvironment in disease progression and outcome has led to treatment improvements by targeting angiogene-sis. Reviews of the underlying biology and meta-analyses of the clinical data tend to be mutually exclusive. This mini-review highlights important data regarding angiogenesis in MM as well as the drugs currently used to target angiogenesis in its treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 39-47 |
| Number of pages | 9 |
| Journal | Current Angiogenesis |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Jan 2014 |
Bibliographical note
Publisher Copyright:© 2014 Bentham Science Publishers
Keywords
- Angiogenesis inhibitors
- Anti angiogenetic agents
- Anti-angiogenic effects
- Immunomodulation
- Multiple myeloma
